v3 Template
E

Elypta

Healthcare/Biotechnology ~620 employees
Founded
--
Employees (Est.)
~620
31 leaders known
Total Funding
$1.0M
Funding Rounds
1
Last Funding
2023-03-28

About Elypta

Elypta is a company focused on advancing cancer detection through pioneering a metabolism-based liquid biopsy. Their mission is to prevent cancer mortality by enabling early detection.

Products & Services

MIRAM(r) Kit:A kit for cancer detection, likely utilizing metabolism-based liquid biopsy technology to measure biomarkers of tumor metabolism.

Specialties

Metabolism-based liquid biopsy Cancer detection Tumor metabolism biomarkers (GAGome) Machine learning for cancer signatures Noninvasive diagnostics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Prize (Grand Prize)
T: -
FT: Prize (Grand Prize) 		A: 1000000
MR: -
FA: $1 million
FAN: 1000000 		D: 2023-03-28
FD: 2023-03-28 		1 investors
Prize (Grand Prize) Latest
2023-03-28
$1.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

K

Karl Bergman

CEO

LinkedIn (Pro only)
F

Francesco Gatto

Founder and Scientific Advisor

LinkedIn (Pro only)
K

Karin Mattsson

VP of Research & Development

LinkedIn (Pro only)
V

Volker Liebenberg

Chief Medical Officer

F

Fredrik Härenstam

Chief Business Officer

J

Johan Vikström

Chief Financial Officer

View 28 more team members with Pro

Unlock Full Team Directory

Recent News

Elypta Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
elypta.com
Industries
Healthcare/Biotechnology
Company Size
~620 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro